For example, ABT‐737 and ABT‐263 were shown to selectively kill senescent cells and blunt the recurrent growth and aggressiveness of cancer cells via interference with BCL‐2, BCL‐XL, and BCL‐W.291, 298, 299. This evidence concerns the gene BCL2 and cancer.